Table 2 Clinical details of patients.

From: Spatial transcriptomics of the epipharynx in long COVID identifies SARS-CoV-2 signalling pathways and the therapeutic potential of epipharyngeal abrasive therapy

Patient number

Age (y)

Sex

Period from infection to start of EAT (months)

Chief complaint

Date of confirmed COVID-19 positivity

Severity of COVID-19

Medical history

BMI, kg/m2

Number of vaccinations before infection

Number of vaccinations after infection

Treatment other than EAT

1

45

F

2

Dizziness

08/2022

Mild

None

18.1

0

0

Nasal irrigation

2

21

M

4

Cough

04/2022

Mild

Chronic sinusitis

20.8

2

0

Nasal irrigation

Low-dose macrolides

Carbocisteine

Mometasone furoate

3

24

M

6

Fatigue

05/2022

Mild

None

24.6

3

0

Nasal irrigation

  1. M, male; F, female; EAT, epipharyngeal abrasive therapy; COVID-19, long-term coronavirus disease 2019; BMI, body mass index.